These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33884726)

  • 1. Antibacterial properties of phenothiazine derivatives against multidrug-resistant Acinetobacter baumannii strains.
    Aguilar-Vega L; López-Jácome LE; Franco B; Muñoz-Carranza S; Vargas-Maya N; Franco-Cendejas R; Hernández-Durán M; Otero-Zúñiga M; Campo-Beleño C; Jiménez-Cortés JG; Martínez-Vázquez M; Rodríguez-Zavala JS; Maeda T; Zurabian R; García-Contreras R
    J Appl Microbiol; 2021 Nov; 131(5):2235-2243. PubMed ID: 33884726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E; Yılmaz M; Özbek Çelik B
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections.
    Cruz-Muñiz MY; López-Jacome LE; Hernández-Durán M; Franco-Cendejas R; Licona-Limón P; Ramos-Balderas JL; Martinéz-Vázquez M; Belmont-Díaz JA; Wood TK; García-Contreras R
    Int J Antimicrob Agents; 2017 Jan; 49(1):88-92. PubMed ID: 27939675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Antibacterial Effect of Phage pB3074 in Combination with Antibiotics Targeting Cell Wall against Multidrug-Resistant Acinetobacter baumannii
    Luo J; Xie L; Yang M; Liu M; Li Q; Wang P; Fan J; Jin J; Luo C
    Microbiol Spectr; 2023 Aug; 11(4):e0034123. PubMed ID: 37260382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of lytic phage T1245 with antibiotics for enhancement of antibacterial and anti-biofilm efficacy against multidrug-resistant
    Soontarach R; Nwabor OF; Voravuthikunchai SP
    Biofouling; 2022 Nov; 38(10):994-1005. PubMed ID: 36606321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii.
    Lima FCG; Oliveira-Júnior JB; Cavalcanti CLB; Veras DL; Freitas CF; Sandes JM; da Silva EM; da Rocha DAM; Alves LC; Brayner FA
    Microb Pathog; 2020 Dec; 149():104437. PubMed ID: 33045338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type IV Pilus-Mediated Inhibition of
    Vo N; Sidner BS; Yu Y; Piepenbrink KH
    Microbiol Spectr; 2023 Aug; 11(4):e0102323. PubMed ID: 37341603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy and mechanism of action of α-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii.
    Pimchan T; Maensiri D; Eumkeb G
    Lett Appl Microbiol; 2017 Oct; 65(4):285-291. PubMed ID: 28799218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant
    Jayathilaka EHTT; Rajapaksha DC; Nikapitiya C; De Zoysa M; Whang I
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069596
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergy of a virulent phage (φAB182) with antibiotics leading to successful elimination of biofilms formed by MDR
    Vashisth M; Yashveer S; Jaglan AB; Virmani N; Bera BC; Vaid RK; Anand T
    Can J Microbiol; 2022 Dec; 68(12):731-746. PubMed ID: 36174234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    Khalil MAF; Moawad SS; Hefzy EM
    J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.